IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 1 filers reported holding IBERE PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,213 | -99.9% | 318,644 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $3,152,000 | -48.1% | 318,644 | -48.5% | 0.01% | +30.0% |
| Q2 2022 | $6,070,000 | +118.7% | 618,852 | +118.1% | 0.01% | +25.0% |
| Q1 2022 | $2,775,000 | +0.7% | 283,686 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $2,755,000 | +0.4% | 283,686 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $2,744,000 | -0.3% | 283,686 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $2,752,000 | – | 283,686 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |